Published in Antimicrob Agents Chemother on April 01, 2002
High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother (2006) 3.38
Regulation of bacterial drug export systems. Microbiol Mol Biol Rev (2002) 3.00
Presence of multidrug-resistant enteric bacteria in dairy farm topsoil. J Dairy Sci (2005) 2.34
Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob Agents Chemother (2002) 1.44
RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob Agents Chemother (2004) 1.40
Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Front Microbiol (2015) 1.29
Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J (2003) 1.28
AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob Agents Chemother (2005) 1.27
Aromatic acid metabolites of Escherichia coli K-12 can induce the marRAB operon. J Bacteriol (2010) 1.01
Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains. Antimicrob Agents Chemother (2004) 0.96
An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins. Antimicrob Agents Chemother (2007) 0.92
The eefABC multidrug efflux pump operon is repressed by H-NS in Enterobacter aerogenes. J Bacteriol (2005) 0.92
Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae: 1-year survey in a French university hospital. Eur J Clin Microbiol Infect Dis (2004) 0.84
Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily. Int J Bacteriol (2015) 0.83
Genetic inactivation of acrAB or inhibition of efflux induces expression of ramA. J Antimicrob Chemother (2013) 0.82
Study of Organic Solvent Tolerance and Increased Antibiotic Resistance Properties in E. coli gyrA Mutants. Iran J Pharm Res (2012) 0.80
ompW is cooperatively upregulated by MarA and SoxS in response to menadione. Microbiology (2013) 0.79
High incidence of multiple antibiotic resistant cells in cultures of in enterohemorrhagic Escherichia coli O157:H7. Mutat Res (2013) 0.78
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother (1997) 4.40
Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol (2000) 3.27
Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences. Proc Natl Acad Sci U S A (1995) 3.09
Overexpression of the MarA positive regulator is sufficient to confer multiple antibiotic resistance in Escherichia coli. J Bacteriol (1993) 2.88
A novel DNA-binding motif in MarA: the first structure for an AraC family transcriptional activator. Proc Natl Acad Sci U S A (1998) 2.77
Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother (1998) 2.59
Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology (1998) 2.51
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother (2000) 2.40
Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother (1996) 2.34
Most Enterobacter aerogenes strains in France belong to a prevalent clone. J Clin Microbiol (1999) 2.05
Plasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strains. Antimicrob Agents Chemother (1998) 2.03
Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob Agents Chemother (1996) 1.93
The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence. J Bacteriol (1997) 1.91
Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J Clin Microbiol (1996) 1.73
Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol (2000) 1.69
A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. J Infect Dis (1993) 1.68
Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob Agents Chemother (2001) 1.55
Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding. Mol Microbiol (2000) 1.54
A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol Microbiol (2001) 1.52
In vivo modification of porin activity conferring antibiotic resistance to Enterobacter aerogenes. Biochem Biophys Res Commun (1999) 1.14
Biological and immunological comparisons of Enterobacter cloacae and Escherichia coli porins. FEMS Microbiol Lett (1995) 1.09
In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR. Antimicrob Agents Chemother (2000) 1.01
Prevalence of the multiple antibiotic resistance operon (marRAB) in the genus Salmonella. FEMS Microbiol Lett (2000) 0.94
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev (2011) 2.46
The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob Agents Chemother (2002) 1.92
Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One (2007) 1.50
Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. J Antimicrob Chemother (2007) 1.43
RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob Agents Chemother (2004) 1.40
Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol (2004) 1.30
Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun (2005) 1.29
Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J (2003) 1.28
Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Curr Drug Targets (2008) 1.26
Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob Agents Chemother (2003) 1.26
Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species. Antimicrob Agents Chemother (2009) 1.26
Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone. Antimicrob Agents Chemother (2010) 1.25
The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob Agents Chemother (2004) 1.20
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators. Antimicrob Agents Chemother (2008) 1.20
Alteration of pore properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop 3 region. Biochem J (2002) 1.18
Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother (2005) 1.14
Implication of porins in beta-lactam resistance of Providencia stuartii. J Biol Chem (2010) 1.14
Identification of an OprD homologue in Acinetobacter baumannii. J Proteome Res (2005) 1.12
Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains. Biochem Biophys Res Commun (2002) 1.11
Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Pat Antiinfect Drug Discov (2006) 1.09
Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother (2005) 1.08
Structural and functional study of the phenicol-specific efflux pump FloR belonging to the major facilitator superfamily. Antimicrob Agents Chemother (2005) 1.08
Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria. FEBS Lett (2011) 1.06
Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003. PLoS One (2008) 1.06
Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem Biophys Res Commun (2004) 1.05
Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicrob Agents (2008) 1.04
Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun (2003) 1.04
Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J Antimicrob Chemother (2006) 1.04
How beta-lactam antibiotics enter bacteria: a dialogue with the porins. PLoS One (2009) 1.04
Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection - bacteria and their synergistic potential with antibiotics. Phytomedicine (2012) 1.03
Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrob Agents Chemother (2010) 0.99
Beta-lactam screening by specific residues of the OmpF eyelet. J Med Chem (2005) 0.99
Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates. Curr Drug Targets (2006) 0.98
A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int J Antimicrob Agents (2003) 0.97
Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains. Antimicrob Agents Chemother (2004) 0.96
Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? PLoS One (2008) 0.95
Corynebacterium freneyi bacteremia. J Clin Microbiol (2003) 0.95
Enterobacter aerogenes OmpX, a cation-selective channel mar- and osmo-regulated. FEBS Lett (2004) 0.94
An instrument-free method for the demonstration of efflux pump activity of bacteria. In Vivo (2006) 0.94
Toward screening for antibiotics with enhanced permeation properties through bacterial porins. Biochemistry (2010) 0.94
Functional refolding of the Campylobacter jejuni MOMP (major outer membrane protein) porin by GroEL from the same species. Biochem J (2004) 0.93
Omp35, a new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins. Antimicrob Agents Chemother (2004) 0.93
An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates. Int J Antimicrob Agents (2012) 0.92
An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins. Antimicrob Agents Chemother (2007) 0.92
Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malaria. Med Chem (2008) 0.92
The eefABC multidrug efflux pump operon is repressed by H-NS in Enterobacter aerogenes. J Bacteriol (2005) 0.92
Aeromonas popoffii urinary tract infection. J Clin Microbiol (2004) 0.91
Environmental regulation of Campylobacter jejuni major outer membrane protein porin expression in Escherichia coli monitored by using green fluorescent protein. Appl Environ Microbiol (2002) 0.91
Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method. In Vivo (2011) 0.91
Efflux pumps of gram-negative bacteria, a new target for new molecules. Curr Top Med Chem (2010) 0.89
Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains. Int J Antimicrob Agents (2010) 0.88
Corynebacterium hansenii sp. nov., an alpha-glucosidase-negative bacterium related to Corynebacterium xerosis. Int J Syst Evol Microbiol (2007) 0.88
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes. Antimicrob Agents Chemother (2009) 0.87
Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution. PLoS One (2012) 0.87
Efflux pumps of gram-negative bacteria: genetic responses to stress and the modulation of their activity by pH, inhibitors, and phenothiazines. Adv Enzymol Relat Areas Mol Biol (2011) 0.87
Colicins, spermine and cephalosporins: a competitive interaction with the OmpF eyelet. Biochem J (2003) 0.87
Efflux mechanism, an attractive target to combat multidrug resistant Plasmodium falciparum and Pseudomonas aeruginosa. Curr Med Chem (2009) 0.86
New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitors. PLoS One (2009) 0.86
Involvement of the efflux pumps in chloramphenicol selected strains of Burkholderia thailandensis: proteomic and mechanistic evidence. PLoS One (2011) 0.86
Antibiotic uptake through membrane channels: role of Providencia stuartii OmpPst1 porin in carbapenem resistance. Biochemistry (2012) 0.84
New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity. J Antimicrob Chemother (2012) 0.83
Propyl paraben induces potassium efflux in Escherichia coli. J Antimicrob Chemother (2005) 0.83
4-alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain. Int J Antimicrob Agents (2003) 0.83